Free CPD event on fume cupboard safety and sustainability at Cambridge Science Park
On February 4th, Clean Air is hosting a free, accredited CPD session at Cambridge Science Park focused on how fume cupboards can be operated more safely and sustainably in commercial laboratories. The session will help attendees better understand the factors that influence containment performance, enabling them to keep laboratory users protected when working with hazardous substances. The CPD…
Accelerate@Babraham applications now open
Starting something new is hard – particularly within the fast-moving life science sector.
Optibrium appoints Dr Nathan Brown as Director of Science
Newly created role underscores commitment to customer-driven research and scientific excellence
Nuclera extends Series C funding to $87M to advance antibody engineering
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK GohThe funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding vWhy cultural literacy has become an execution skill in life sciences
In life sciences, execution failures are often explained in familiar terms: regulatory complexity, funding constraints, or technological readiness. Yet in practice, many promising initiatives stall or unravel for a quieter reason — misaligned assumptions between people, professions and systems.
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
Oversubscribed £2.5M seed round led by Ahren Innovation CapitalStrategic collaboration with o2h to progress drug discovery programmeCambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company pioneering a unique AI-ba
iXCells Biotechnologies appoints Steve Smith as CEO
Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services
FairJourney Bio launches cryo-EM services with advanced laboratories in San Diego, USA
Expanded offering provides high-resolution structural insights to support antibody discovery and biologic design
Qureight appoints Rebecca Simmons as Chief Operating Officer
Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operations
Advancing UK MedTech innovation with collaboration - London Institute for Healthcare Engineering partnership with Team Consulting
Team Consulting is delighted to announce a new collaboration with the London Institute for Healthcare Engineering (LIHE), part of King’s College London. Drawing on our 40-year track record in healthcare innovation, this partnership marks an acceleration in the journey from breakthrough ideas to market-ready medical technologies.
Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases
Why 454 million people are waiting for a device already in their pocket
The Smartphone Revolution in Respiratory Care Has Arrived, And It Changes Everything
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P.
From speed to proof: what happens when innovation meets system maturity
For many founders, the early phase of innovation is familiar territory. A strong idea gains traction, early pilots show promise, and momentum builds around speed — speed to prototype, speed to market, speed to scale.
Nuclera eProtein Discovery System installed at leading Universities in Taiwan
Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in AsiaSystem strengthens Taiwan’s capabilities in protein drug discovery researchCambridge, UK, and Bo
Qureight appoints Dr Steven Bishop as Chief Medical Officer
Change in role from Chief Data Officer reflects Qureight’s continued growth and commercial success in delivering customers’ clinical studies
Why gene therapy matters now
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new situation review on the FDA approved "classical" gene therapy landscape.
Royal College Fellowship joy for three CPFT psychiatrists
Three psychiatrists at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) have been awarded prestigious Fellowships by the Royal College of Psychiatrists, honouring their outstanding contributions to mental health care and research.
University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare
The University of Cambridge, AstraZeneca and Beijing municipal parties (the Beijing Science and Technology Commission and the Beijing Economic and Technological Development Area), have signed an agreement that will enhance collaboration between the University, AstraZeneca and Cambridge and Beijing’s life sciences ecosystems.
Share your views - The Institute for Biomedical Innovation (IBI)
The Institute for Biomedical Innovation (IBI) is a new major investment by the University of Cambridge. Based in the Department of Engineering, the IBI aims to turn early-stage medical technologies into safe, sustainable, clinically ready devices.
UK CFOs upbeat on tech investment and potential for AI to boost productivity for year ahead
More than half of finance chiefs (59%) have become more optimistic over the past 12 months on the potential for AI to boost the performance of their organisation, up from 39% in Q3 of 2024; Almost all of them (96%) expect to see a rise in investment in digital technology and assets by UK companies in the next five years; Corporate risk appetite (15%) has edged up from the lows seen in…
FUJIFILM Irvine Scientific now officially FUJIFILM Biosciences
Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official
A practical introduction to developing your first product in 2026
If you’ve ever caught yourself circling an idea on a quiet Sunday evening, just as the working week looms, this is likely for you. It’s the idea that pops up when things slow down. The one you scribble into a notes app, then leave untouched.
Why a content audit is one of the most valuable exercises Life Sciences marketing teams overlook
A practical, leadership-level view of how content audits help Life Sciences teams regain clarity, reduce waste and drive stronger commercial impact.
Planning a high ROI webinar: What it really takes to make them work in Life Sciences
Learn what it really takes to plan, execute, and extract lasting ROI from webinars in Life Sciences marketing.